药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Papaverine
Bendamustine
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Bendamustine.
Papaverine
Belatacept
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Belatacept.
Papaverine
Golimumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Golimumab.
Papaverine
Abetimus
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Abetimus.
Papaverine
Bosutinib
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Bosutinib.
Papaverine
Mepolizumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Mepolizumab.
Papaverine
Panobinostat
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Panobinostat.
Papaverine
Pazopanib
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Pazopanib.
Papaverine
Rilonacept
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Rilonacept.
Papaverine
Temsirolimus
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Temsirolimus.
Papaverine
Tocilizumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Tocilizumab.
Papaverine
Canakinumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Canakinumab.
Papaverine
Trastuzumab emtansine
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Trastuzumab emtansine.
Papaverine
Apremilast
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Apremilast.
Papaverine
Human interferon omega-1
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Human interferon omega-1.
Papaverine
Briakinumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Briakinumab.
Papaverine
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Gallium nitrate.
Papaverine
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Gallium nitrate.
Papaverine
Trabectedin
The risk or severity of adverse effects can be increased when Trabectedin is combined with Gallium nitrate.
Papaverine
Afelimomab
The risk or severity of adverse effects can be increased when Afelimomab is combined with Gallium nitrate.